Table 2 Target office blood pressure of hypertension treatment for the patients with comorbidity

From: Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022

 

General

Comorbidity

Diabetes

CKD

Elderly

CAD

Heart failure

Stroke

ISH [21]

–

<130/80

<130/80

<140/90

<130/80

<130/80

<130/80

AHA/ACC [22]

–

<130/80

<130/80

<130

<130/80

<130/80

<130/80

ESC/ESH [23]

–

120–130/70–79

120–130/70–79

130–140/70–79

130–140/70–79

–

130–140/70–79

HOPE-ASIA

–

–

–

–

–

–

–

Asian regions

China [25]

<140/90

<130/80

<140/90a

<130/80b

<150/90

<140/90

<130/80

<140/90

India [26]

<140/90

<140/80

<140/80

<140/80i

140–145j

–

–

<135/85

Indonesia

<130/70–79

<130/70–79

<140/70–79

<130–139/70–79k

<130–139/70–79j

<130/70–79

–

<130

Korea [27]

<140/90

<140/85

<140/90c

<130/80d

<140/90

<130/80

<130/80

<130/80

Malaysia [28]

<140/90

<140/80

<140/90e

<130/80f

<140k

<150j

<130/80

–

<140/90

<130/80q

Mongolia [29]

<130/80

<130/80

<130/80

<150/80

<130/80

–

–

Pakistan [30]

<140/90

<130/80

<130/80

<140/90k

<150/90j

<130/80

<130/80

<130/80

Philippines [31]

<130/80

120–130/90

<140/90g

<130/80h

<140/90j

–

–

<130/80

Singapore [32]

<140/90

<140/80

<130/80

<140/90l

<150/90j

–

–

–

Sri Lanka [33]

<130/80

–

<130/80

<140/80

<130/80

–

–

Taiwan [34]

<130/80

<130/80

<130

<120r

<130n

<130/80

<130

<130/80

Thailand [35]

120–130/70–79

120–130/70–79

120–130/70–79

130–139/70–79n

120–130/70–79

120–130/<80

120–130/70–79

Vietnam [36]

<140/80

120–130/<80

120–130/70–79

<140/80o

120–130/70–79

110–130/<80

120–130/70–79

Japan [37]

<130/80

<130/80

<140/90a

<130/80b

<130/80p

<140/90m

<130/80

–

<130/80

  1. AHA/ACC American Heart Association/American College of Cardiology, BP blood pressure, CAD coronary artery disease, CKD chronic kidney disease, ESC/ESH European Society of Cardiology/European Society of Hypertension, ISH International Society of Hypertension
  2. aUrine protein (−), bUrine protein (+), cUrine albuminuria (−), dUrine albuminuria (+), eUrine protein <1 g/day, fUrine protein ≥1 g/day, gLow cardiovascular risk and CKD stage 3 or 4, hHigh cardiovascular risk or CKD stage 3, i55–79 years, j≥80 years, k65–79 years, l<80 years, m≥75 years, n≥65 years, o≥70 years, p65–75 years, qLacuna stroke, rIf well-tolerated
Back to article page